A detailed history of Robbins Farley LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Robbins Farley LLC holds 3 shares of CRSP stock, worth $154. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3
Previous 3 -0.0%
Holding current value
$154
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 23, 2023

BUY
$45.39 - $59.0 $136 - $177
3 New
3 $0
Q3 2022

Nov 14, 2022

BUY
$61.1 - $83.78 $183 - $251
3 New
3 $0
Q2 2022

Aug 15, 2022

SELL
$43.23 - $73.83 $129 - $221
-3 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$53.19 - $79.24 $159 - $237
3 New
3 $0

Others Institutions Holding CRSP

About CRISPR Therapeutics AG


  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $4.03B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Robbins Farley LLC Portfolio

Follow Robbins Farley LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Robbins Farley LLC, based on Form 13F filings with the SEC.

News

Stay updated on Robbins Farley LLC with notifications on news.